Hayek Kallen Investment Management Zoetis Inc. Transaction History

Hayek Kallen Investment Management

$294 Million
Q2 2025

A detailed history of Hayek Kallen Investment Management transactions in Zoetis Inc. stock. As of the latest transaction made, Hayek Kallen Investment Management holds 2,121 shares of ZTS stock, worth $263,979. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,121

Previous 3,263 35.0%

Holding current value

$263,979

Previous $537,000 38.36%

% of portfolio

0.11%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$144.41 - $170.3 $164,916 - $194,482	-1,142 Reduced 35.0%	2,121 $331,000
Q1 2025 May 15, 2025	SELL	$156.48 - $175.67 $700,717 - $786,650	-4,478 Reduced 57.85%	3,263 $537,000
Q4 2024 Feb 14, 2025	SELL	$162.24 - $194.42 $105,456 - $126,372	-650 Reduced 7.75%	7,741 $1.26 Million
Q3 2024 Oct 15, 2024	SELL	$172.58 - $196.48 $36,932 - $42,046	-214 Reduced 2.49%	8,391 $1.64 Million
Q2 2024 Jul 18, 2024	SELL	$145.54 - $178.83 $42,934 - $52,754	-295 Reduced 3.31%	8,605 $1.49 Million
Q1 2024 May 03, 2024	SELL	$165.67 - $199.94 $61,132 - $73,777	-369 Reduced 3.98%	8,900 $1.51 Million
Q4 2023 Feb 08, 2024	BUY	$151.44 - $200.09 $4,694 - $6,202	31 Added 0.34%	9,269 $1.83 Million
Q3 2023 Nov 07, 2023	SELL	$167.14 - $192.77 $14,541 - $16,770	-87 Reduced 0.93%	9,238 $1.61 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $84,654 - $97,956	526 Added 5.98%	9,325 $1.61 Million
Q1 2023 May 08, 2023	SELL	$145.48 - $175.02 $36,224 - $43,579	-249 Reduced 2.75%	8,799 $1.47 Million
Q4 2022 Feb 09, 2023	BUY	$131.14 - $157.47 $38,161 - $45,823	291 Added 3.32%	9,048 $1.33 Million
Q3 2022 Oct 19, 2022	SELL	$148.29 - $182.55 $13,939 - $17,159	-94 Reduced 1.06%	8,757 $1.3 Million
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $3,119 - $4,001	20 Added 0.23%	8,851 $1.52 Million
Q1 2022 May 09, 2022	BUY	$181.39 - $234.03 $109,015 - $140,652	601 Added 7.3%	8,831 $1.67 Million
Q4 2021 Feb 08, 2022	SELL	$193.69 - $247.03 $55,782 - $71,144	-288 Reduced 3.38%	8,230 $2.01 Million
Q3 2021 Oct 06, 2021	SELL	$189.29 - $209.69 $29,339 - $32,501	-155 Reduced 1.79%	8,518 $1.65 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $31,959 - $38,537	205 Added 2.42%	8,673 $1.62 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $33,984 - $39,976	236 Added 2.87%	8,468 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $92,671 - $102,866	590 Added 7.72%	8,232 $1.36 Million
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $45,243 - $54,572	330 Added 4.51%	7,642 $1.26 Million
Q2 2020 Sep 10, 2020	BUY	$111.92 - $142.53 $818,359 - $1.04 Million	7,312 New	7,312 $1 Million

Others Institutions Holding ZTS

# of Institutions

2,123

Shares Held

432M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $58.3B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.

Account

Hayek Kallen Investment Management Zoetis Inc. Transaction History